Cargando…
Immune microenvironment analysis and novel biomarkers of early-stage lung adenocarcinoma evolution
BACKGROUND: Lung cancer is the deadliest and most diagnosed type of cancer worldwide. The 5-year survival rate of lung adenocarcinoma (LUAD) dropped significantly when tumor stages advanced. Patients who received surgically resecting at the pre-invasive stage had a 5-year survival rate of nearly 100...
Autores principales: | Liu, Jun, Ji, Yaxin, Weng, Xiaodan, Shao, Wei, Zhao, Jiaping, Chen, Hanlin, Shen, Lu, Wang, Fufeng, Meng, Qi, Wu, Xue, Wang, Xiaonan, Ou, Qiuxiang, Ke, Honggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328385/ https://www.ncbi.nlm.nih.gov/pubmed/37427097 http://dx.doi.org/10.3389/fonc.2023.1150098 |
Ejemplares similares
-
Baseline Mutations and Up-Regulation of PI3K-AKT Pathway Serve as Potential Indicators of Lack of Response to Neoadjuvant Chemotherapy in Stage II/III Breast Cancer
por: Dong, Menghao, et al.
Publicado: (2022) -
Durable Complete Response to Alectinib in a Lung Adenocarcinoma Patient With Brain Metastases and Low-Abundance EML4-ALK Variant in Liquid Biopsy: A Case Report
por: Zhu, Yingying, et al.
Publicado: (2020) -
Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer
por: Wang, Qiang, et al.
Publicado: (2021) -
Potential Metabolite Biomarkers for Early Detection of Stage-I Pancreatic Ductal Adenocarcinoma
por: Cao, Yingying, et al.
Publicado: (2022) -
Comprehensive genomic profiling of colorectal cancer patients reveals differences in mutational landscapes among clinical and pathological subgroups
por: Li, Peng, et al.
Publicado: (2022)